| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000058431.78833.F5 |
| P698 | PubMed publication ID | 12615695 |
| P50 | author | Miranda Van Eck | Q60628879 |
| P2093 | author name string | Jian Guo | |
| Theo J C Van Berkel | |||
| Nobuyo Maeda | |||
| Jaap Twisk | |||
| G Martin Benson | |||
| Pieter H E Groot | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 447-453 | |
| P577 | publication date | 2003-01-30 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis | |
| P478 | volume | 23 |
| Q38936733 | A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy |
| Q24300694 | An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion |
| Q33738515 | Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice |
| Q37978508 | Bone marrow transplantation as an established approach for understanding the role of macrophages in atherosclerosis and the metabolic syndrome |
| Q33533950 | CCR2 and coronary artery disease: a woscops substudy |
| Q37652971 | Chemokines in the vascular inflammatory response of atherosclerosis |
| Q35640438 | Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. |
| Q35159004 | Deficiency of the sialyltransferase St3Gal4 reduces Ccl5-mediated myeloid cell recruitment and arrest: short communication |
| Q34340622 | Evidence for C-reactive protein's role in (CRP) vascular disease: atherothrombosis, immuno-regulation and CRP. |
| Q52950456 | Freely associating with chemokine receptor 2 polymorphisms and atherosclerosis. |
| Q54658035 | Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. |
| Q42288906 | Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis |
| Q37446568 | Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis |
| Q42532089 | Lack of tyrosylprotein sulfotransferase activity in hematopoietic cells drastically attenuates atherosclerosis in Ldlr-/- mice |
| Q46849328 | Linoleic acid-rich fats reduce atherosclerosis development beyond its oxidative and inflammatory stress-increasing effect in apolipoprotein E-deficient mice in comparison with saturated fatty acid-rich fats |
| Q35251005 | Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata |
| Q38125279 | Molecular biology of atherosclerosis |
| Q33867271 | Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis. |
| Q27003124 | Regulation of atherogenesis by chemokines and chemokine receptors |
| Q36831073 | The downstream regulation of chemokine receptor signalling: implications for atherosclerosis |
Search more.